SCHEMBL31465365

SCHEMBL31465365

Nc1c(Br)c(C(F)F)nc2c(Cl)cnn12.[N]

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 3/20 0.32
▸ CDK2 P24941 3/20 0.32
▸ CCNA1 P78396 3/20 0.32
▸ CCNT1 O60563 2/20 0.32
▸ CDK1 P06493 2/20 0.32
▸ CDK4 P11802 2/20 0.32
▸ CCND1 P24385 2/20 0.32
▸ CCNE1 P24864 2/20 0.32
▸ CDK7 P50613 2/20 0.32
▸ CDK9 P50750 2/20 0.32
▸ CCNH P51946 2/20 0.32
▸ CDK3 Q00526 2/20 0.32
▸ CDK6 Q00534 2/20 0.32
▸ CDK5 Q00535 2/20 0.32
▸ CDK5R1 Q15078 2/20 0.32
▸ CHEK1 O14757 1/20 0.32
▸ CCNC P24863 1/20 0.32
▸ CDK8 P49336 1/20 0.32
▸ ABL1 P00519 1/20 0.31
▸ KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31465415 0.98 CCNA2 (0.32) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL31465375 0.68 — —
SCHEMBL31465353 0.68 CDK2 (0.41) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL23242838 0.65 CCNA2 (0.33) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL23267657 0.65 MEN1 (0.35) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL11930853 0.64 AKT1 (0.39) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL31465349 0.64 CDK2 (0.40) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL31465380 0.64 CCNT1 (0.34) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL31465387 0.63 KMT2A (0.39) CCNA2CDK2CCNA1CCNT1CDK1
SCHEMBL31465339 0.62 CCNT1 (0.34) CCNA2CDK2CCNA1CCNT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025068090-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2025-04-03 — — WO disclosed
Send feedback